{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:28:55Z","timestamp":1787110135069,"version":"build-2736575974"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.critrevonc.2026.105428","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T05:47:19Z","timestamp":1780811239000},"page":"105428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bridging the gap between infection and detection: Biological, clinical, and health system contributors to diagnostic delay in HPV-associated cervical cancer"],"prefix":"10.1016","volume":"225","author":[{"given":"Breanna R.","family":"Buhay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeson D.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Y.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Wakefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105428_bib1","unstructured":"ACOG Responds to Updated HRSA Women\u2019s Preventive Services Initiative Guidelines on Cervical Cancer Screening. (n.d.). Retrieved January 8, 2026, from \u3008https:\/\/www.acog.org\/news\/news-releases\/2026\/01\/acog-responds-to-updated-hrsa-womens-preventive-services-initiative-guidelines-on-cervical-cancer-screening\u3009."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105428_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/v9100293","article-title":"Why human Papillomavirus acute infections matter","volume":"9","author":"Alizon","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.critrevonc.2026.105428_bib3","doi-asserted-by":"crossref","first-page":"k4823","DOI":"10.1136\/bmj.k4823","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105428_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e14289","article-title":"Women\u2019s critical experiences with the pap smear for the development of cervical cancer screening devices","volume":"9","author":"Arrivillaga","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.critrevonc.2026.105428_bib5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s12967-025-06470-x","article-title":"Human papilloma virus (HPV) mediated cancers: an insightful update","volume":"23","author":"Baba","year":"2025","journal-title":"J. Transl. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105428_bib6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/vaccines13060640","article-title":"Prevalence of vaccine-covered and non-covered hpv genotypes among unvaccinated women in ankara: a single-center study","volume":"13","author":"Bak\u0131r","year":"2025","journal-title":"Vaccines"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105428_bib7","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3390\/vaccines12090956","article-title":"The clinical effectiveness of single-dose human papillomavirus vaccination","volume":"12","author":"Bao","year":"2024","journal-title":"Vaccines"},{"issue":"24","key":"10.1016\/j.critrevonc.2026.105428_bib8","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1056\/NEJMe2515387","article-title":"Evidence to action\u2014single-dose HPV vaccination and cervical HPV infection","volume":"393","author":"Barnabas","year":"2025","journal-title":"New. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105428_bib9","first-page":"991","article-title":"Progress toward cervical cancer elimination: Global disparities and China\u2019s contributions","volume":"22","author":"Basu","year":"2025","journal-title":"Cancer Biol. & Med."},{"key":"10.1016\/j.critrevonc.2026.105428_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1311286","article-title":"Concept mapping sociocultural aspects of cervical cancer prevention among African American women","volume":"11","author":"Carmack","year":"2024","journal-title":"Front. Public. Health"},{"key":"10.1016\/j.critrevonc.2026.105428_bib11","unstructured":"Cervical cancer elimination initiative. (n.d.). Retrieved August 3, 2021, from \u3008https:\/\/www.who.int\/initiatives\/cervical-cancer-elimination-initiative\u3009."},{"key":"10.1016\/j.critrevonc.2026.105428_bib12","unstructured":"Cervical cancer: Learn More \u2013 Pap and HPV screening tests for early detection of cervical cancer. (2025). In InformedHealth.org [Internet]. Institute for Quality and Efficiency in Health Care (IQWiG). \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279258\/\u3009."},{"key":"10.1016\/j.critrevonc.2026.105428_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3257939","article-title":"Human Papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination\u2014review of current perspectives","volume":"2019","author":"Chan","year":"2019","journal-title":"J. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105428_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109716","article-title":"Advances in molecular mechanism of HPV16 E5 oncoprotein carcinogenesis","volume":"745","author":"Chen","year":"2023","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.critrevonc.2026.105428_bib15","unstructured":"CHIC HPV Council Consensus Statement on One-Dose Recommendation. (n.d.). CHIC. Retrieved January 6, 2026, from \u3008https:\/\/stophpv.org\/chic-hpv-council-consensus-statement-on-one-dose-recommendation\/\u3009."},{"key":"10.1016\/j.critrevonc.2026.105428_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103127","article-title":"The Global Fund, Cervical Cancer, and HPV infections: what can low- and middle-income countries do to accelerate progress by 2030?","volume":"81","author":"Chidebe","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.critrevonc.2026.105428_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103127","article-title":"The global fund, cervical cancer, and HPV infections: what can low- and middle-income countries do to accelerate progress by 2030?","volume":"81","author":"Chidebe","year":"2025","journal-title":"eClinicalMedicine"},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105428_bib18","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2026.105428_bib19","unstructured":"Colposcopy and treatment of cervical intraepithelial neoplasia: A beginners\u2019 manual. (n.d.). Retrieved January 6, 2026, from \u3008https:\/\/screening.iarc.fr\/colpochap.php?chap=2\u3009."},{"key":"10.1016\/j.critrevonc.2026.105428_bib20","series-title":"StatPearls","article-title":"Preventing Cervical Cancer: Best Practices in Pap and HPV Testing","author":"Crifase","year":"2025"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105428_bib21","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.3390\/ijms22052294","article-title":"P16 and HPV genotype significance in hpv-associated cervical cancer\u2014a large cohort of two tertiary referral centers","volume":"22","author":"da Mata","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"S1","key":"10.1016\/j.critrevonc.2026.105428_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.15600","article-title":"Turning the tide\u2014Recommendations to increase cervical cancer screening among women who are underscreened","volume":"166","author":"Descamps","year":"2024","journal-title":"Int. J. Gynecol. Obstet."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105428_bib23","doi-asserted-by":"crossref","first-page":"8476","DOI":"10.3390\/cimb45100534","article-title":"The Role of p16\/Ki67 dual staining in cervical cancer screening","volume":"45","author":"Dovnik","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.critrevonc.2026.105428_bib24","series-title":"StatPearls","article-title":"Cervical Cancer","author":"Fowler","year":"2025"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105428_bib25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1309\/AJCPSD3ZXJXP7NNB","article-title":"Cervical histopathology variability among laboratories","volume":"139","author":"Gage","year":"2013","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105428_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.socscimed.2016.04.028","article-title":"Parental acceptance and uptake of the HPV vaccine among African-Americans and Latinos in the United States: a literature review","volume":"159","author":"Galbraith","year":"2016","journal-title":"Social. Sci. & Med."},{"key":"10.1016\/j.critrevonc.2026.105428_bib27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.socscimed.2016.04.028","article-title":"Parental acceptance and uptake of the HPV vaccine among African-Americans and Latinos in the United States: a literature review","volume":"159","author":"Galbraith","year":"2016","journal-title":"Social. Sci. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105428_bib28","first-page":"53","article-title":"Practical Issues of Ki-67 evaluation in breast cancer clinical practice","volume":"2","author":"Hacking","year":"2022","journal-title":"J. Clin. Transl. Pathol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105428_bib29","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/ijc.35353","article-title":"P16\/ki-67 dual stain triage of individuals positive for HPV to detect cervical precancerous lesions","volume":"156","author":"Harper","year":"2025","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105428_bib30","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1158\/1078-0432.CCR-10-2548","article-title":"Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human Papillomavirus DNA\u2013positive women","volume":"17","author":"Hesselink","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105428_bib31","unstructured":"HPV and Cancer - NCI. (2019a, March 1). [cgvArticle]. (nciglobal,ncienterprise). \u3008https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/infectious-agents\/hpv-and-cancer\u3009."},{"key":"10.1016\/j.critrevonc.2026.105428_bib32","unstructured":"HPV and Cancer - NCI. (2019b, March 1). [cgvArticle]. (nciglobal,ncienterprise). \u3008https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/infectious-agents\/hpv-and-cancer\u3009."},{"key":"10.1016\/j.critrevonc.2026.105428_bib33","unstructured":"HPV Self-collection Test. (n.d.). Retrieved January 8, 2026, from \u3008https:\/\/www.cancer.org\/cancer\/risk-prevention\/hpv\/hpv-and-hpv-testing\/self-collection.html\u3009."},{"key":"10.1016\/j.critrevonc.2026.105428_bib34","unstructured":"HPV Vaccination. (n.d.). Retrieved December 21, 2025, from \u3008https:\/\/progressreport.cancer.gov\/prevention\/hpv_immunization\u3009."},{"key":"10.1016\/j.critrevonc.2026.105428_bib35","unstructured":"HPV Vaccine Administration (CDC). (2023, May 22). \u3008https:\/\/www.cdc.gov\/vaccines\/vpd\/hpv\/hcp\/administration.html\u3009."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105428_bib36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/0033354920925094","article-title":"Persistent disparities in cervical cancer screening uptake: knowledge and sociodemographic determinants of papanicolaou and human Papillomavirus testing among women in the United States","volume":"135","author":"Johnson","year":"2020","journal-title":"Public. Health Rep. \u00ae"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105428_bib37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/scbi.1996.0042","article-title":"Interactions of the human papillomavirus E7 protein with cell cycle regulators","volume":"7","author":"Jones","year":"1996","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105428_bib38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/life15030367","article-title":"Enhancing cervical cancer screening: new diagnostic methodologies, triage, and risk stratification in prevention and treatment","volume":"15","author":"Kamzayeva","year":"2025","journal-title":"Life"},{"key":"10.1016\/j.critrevonc.2026.105428_bib39","unstructured":"Ki-67 Is a Controversial Prognostic Biomarker in Early-Stage Breast Cancer. Here\u2019s Why. (n.d.). Retrieved January 6, 2026, from \u3008https:\/\/dailynews.ascopubs.org\/do\/10.1200\/ADN.22.201207\/full\/\u3009."},{"key":"10.1016\/j.critrevonc.2026.105428_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1573576","article-title":"The promise of PD1\/PDL1 targeted immunotherapy in locally advanced cervical cancer: a game-changer for patients outcome?","volume":"16","author":"Kouhen","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105428_bib41","series-title":"StatPearls","article-title":"Koilocytosis","author":"Krause","year":"2025"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105428_bib42","doi-asserted-by":"crossref","first-page":"682","DOI":"10.2353\/ajpath.2008.080280","article-title":"Koilocytosis","volume":"173","author":"Krawczyk","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105428_bib43","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.3390\/cancers14163954","article-title":"Combined Liquid Biopsy Methylation Analysis of CADM1 and MAL in Cervical Cancer Patients","volume":"14","author":"Leffers","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105428_bib44","doi-asserted-by":"crossref","first-page":"186.e1","DOI":"10.1016\/j.ajog.2025.02.032","article-title":"Delay to timely treatment in locally advanced cervical cancer: insurance inequities in access to gynecologic oncology","volume":"233","author":"Liang","year":"2025","journal-title":"Am. J. Obstet. & Gynecol."},{"issue":"627","key":"10.1016\/j.critrevonc.2026.105428_bib45","doi-asserted-by":"crossref","first-page":"e602","DOI":"10.3399\/bjgp14X681757","article-title":"Delays in diagnosis of young females with symptomatic cervical cancer in England: an interview-based study","volume":"64","author":"Lim","year":"2014","journal-title":"Br. J. General. Pract."},{"key":"10.1016\/j.critrevonc.2026.105428_bib46","first-page":"iv72","article-title":"Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020","volume":"28","author":"Marth","year":"2017","journal-title":"Ann. Oncol. ESMO Update Clin. Pract. Guidel."},{"key":"10.1016\/j.critrevonc.2026.105428_bib47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13643-023-02252-y","article-title":"HPV self-sampling versus healthcare provider collection on the effect of cervical cancer screening uptake and costs in LMIC: a systematic review and meta-analysis","volume":"12","author":"Mekuria","year":"2023","journal-title":"Syst. Rev."},{"key":"10.1016\/j.critrevonc.2026.105428_bib48","unstructured":"Mello, V., & Sundstrom, R.K. (2025). Cervical Intraepithelial Neoplasia. In StatPearls. StatPearls Publishing. \u3008http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK544371\/\u3009."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105428_bib49","first-page":"7166","article-title":"Methylation of CADM1 and MAL together with HPV status in cytological cervical specimens serves an important role in the progression of cervical intraepithelial neoplasia","volume":"16","author":"Mer\u0161akov\u00e1","year":"2018","journal-title":"Oncol. Lett."},{"issue":"14","key":"10.1016\/j.critrevonc.2026.105428_bib50","doi-asserted-by":"crossref","first-page":"7616","DOI":"10.3390\/ijms25147616","article-title":"HPV infections\u2014classification, pathogenesis, and potential new therapies","volume":"25","author":"Mlynarczyk-Bonikowska","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105428_bib51","article-title":"Limitation of cytology and the impact on reduction of cervical cancer","volume":"34","author":"Monteiro","year":"2022","journal-title":"Braz. J. Sex. Transm. Dis."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105428_bib52","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.18632\/oncotarget.1523","article-title":"P16 in HPV-associated cancers","volume":"4","author":"Munger","year":"2013","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105428_bib53","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029158","article-title":"HPV self-sampling acceptability in rural and indigenous communities in Guatemala: a cross-sectional study","volume":"9","author":"Murchland","year":"2019","journal-title":"BMJ Open."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105428_bib54","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijgo.2015.07.024","article-title":"Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy","volume":"132","author":"Mustafa","year":"2016","journal-title":"Int. J. Gynaecol. Obstet. Off. Organ. Int. Fed. Gynaecol. Obstet."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105428_bib55","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41379-019-0360-3","article-title":"Prognostic implications of genotyping and p16 immunostaining in HPV-positive tumors of the uterine cervix","volume":"33","author":"Nicol\u00e1s","year":"2020","journal-title":"Mod. Pathol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105428_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263615","article-title":"Programme death ligand 1 expressions as a surrogate for determining immunotherapy in cervical carcinoma patients","volume":"17","author":"Omenai","year":"2022","journal-title":"PLOS ONE"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105428_bib57","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/diagnostics14040451","article-title":"Enhancing cervical cancer screening: review of p16\/Ki-67 dual staining as a promising triage strategy","volume":"14","author":"Ouh","year":"2024","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105428_bib58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5468\/ogs.24236","article-title":"Significance and limitations of routine p16\/Ki-67 immunohistochemistry as a diagnostic tool for high-grade squamous intraepithelial lesions of the uterine cervix","volume":"68","author":"Ozono","year":"2025","journal-title":"Obstet. Gynecol. Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105428_bib59","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/cncy.22103","article-title":"Meta-analysis of the accuracy of p16 or p16\/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+\/CIN3+ in triage of women with minor abnormal cytology","volume":"127","author":"Peeters","year":"2019","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.critrevonc.2026.105428_bib60","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7430a1","article-title":"Vaccination Coverage Among Adolescents Aged 13\u201317 Years\u2014National Immunization Survey-Teen, United States, 2024","volume":"74","author":"Pingali","year":"2025","journal-title":"Mmwr. Morb. Mortal. Wkly. Report."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105428_bib61","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1470-2045(18)30763-0","article-title":"Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial","volume":"20","author":"Polman","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105428_bib62","article-title":"Preferences Among U.S. Women for cervical cancer screening with self-collected specimens for human Papillomavirus Testing","author":"Qin","year":"2022","journal-title":"Obstet. & Gynecol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105428_bib63","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2017.12.010","article-title":"Delays in definitive cervical cancer treatment: an analysis of disparities and overall survival impact","volume":"149","author":"Ramey","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105428_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2019.105968","article-title":"Factors associated with adolescent HPV vaccination in the U.S.: a systematic review of reviews and multilevel framework to inform intervention development","volume":"131","author":"Rodriguez","year":"2020","journal-title":"Prev. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105428_bib65","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/jso.26687","article-title":"Epidemiology and incidence of HPV-related cancers of the head and neck","volume":"124","author":"Roman","year":"2021","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105428_bib66","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7012a2","article-title":"Declines in prevalence of human papillomavirus vaccine-type infection among females after introduction of vaccine\u2014United States, 2003\u20132018","volume":"70","author":"Rosenblum","year":"2021","journal-title":"Mmwr. Morb. Mortal. Wkly. Report."},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105428_bib67","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1158\/0008-5472.CAN-24-3989","article-title":"HPV E5 mediates resistance to chemotherapy and radiation by promoting a stem cell\u2013like phenotype in head and neck squamous cell carcinoma","volume":"85","author":"Roy","year":"2025","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105428_bib68","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ogc.2007.09.004","article-title":"Cervical cancer prevention - cervical screening: science in evolution","volume":"34","author":"Safaeian","year":"2007","journal-title":"Obstet. Gynecol. Clin. North. Am."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105428_bib69","article-title":"PD-1\/PD-L1 immune checkpoint inhibitors in advanced cervical cancer","volume":"5","author":"Saglam","year":"2018","journal-title":"Integr. Cancer Sci. Ther."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105428_bib70","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0002-9440(10)65689-1","article-title":"Expression Status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions","volume":"153","author":"Sano","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105428_bib71","article-title":"Insurance status and time to radiation care after pathologic diagnosis for cervical cancer patients","volume":"47","author":"Saris","year":"2023","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.critrevonc.2026.105428_bib72","unstructured":"Screening and treatment of precancerous lesions for secondary prevention of cervical cancer technology landscape report. (n.d.)."},{"key":"10.1016\/j.critrevonc.2026.105428_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106900","article-title":"Worldwide use of HPV self-sampling for cervical cancer screening","volume":"154","author":"Serrano","year":"2022","journal-title":"Prev. Med."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105428_bib74","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/v9080229","article-title":"Targeting persistent human papillomavirus infection","volume":"9","author":"Shanmugasundaram","year":"2017","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105428_bib75","doi-asserted-by":"crossref","first-page":"80","DOI":"10.34172\/hpp.42485","article-title":"Exploring the barriers to Pap smear test compliance: a qualitative study for improving cervical cancer screening in the primary health care","volume":"14","author":"Shariati Sarcheshme","year":"2024","journal-title":"Health Promot. Perspect."},{"key":"10.1016\/j.critrevonc.2026.105428_bib76","article-title":"Identifying the key barriers, facilitators and factors associated with cervical cancer screening attendance in young women: a systematic review","volume":"21","author":"Shpendi","year":"2025","journal-title":"Women\u2019S. Health"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105428_bib77","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA A Cancer Journal Clinicians"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105428_bib78","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1016\/j.ymthe.2025.08.033","article-title":"Targeted degradation of the HPV oncoprotein E6 reduces tumor burden in cervical cancer","volume":"33","author":"Smalley","year":"2025","journal-title":"Mol. Therapy J. Am. Soc. Gene Therapy"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105428_bib79","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/1055-9965.EPI-23-0038","article-title":"Racial\/ethnic disparities in cervical cancer stage at diagnosis: mediating effects of neighborhood-level socioeconomic deprivation","volume":"32","author":"Sokale","year":"2023","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105428_bib80","first-page":"123","article-title":"Underdiagnosis of cervical intraepithelial neoplasia (CIN) 2 or Worse Lesion in Women with a Previous Colposcopy-Guided Biopsy Showing CIN 1","volume":"39","author":"Souza","year":"2017","journal-title":"RBGO Gynecol. Obstet."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105428_bib81","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.amepre.2023.04.016","article-title":"Racial and ethnic disparities in cervical cancer screening from three U.S. healthcare settings","volume":"65","author":"Spencer","year":"2023","journal-title":"Am. J. Prev. Med."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105428_bib82","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2026.105428_bib83","unstructured":"Strategic Advisory Group of Experts on Immunization (SAGE) - April 2022. (n.d.). Retrieved January 6, 2026, from \u3008https:\/\/www.who.int\/news-room\/events\/detail\/2022\/04\/04\/default-calendar\/sage_meeting_april_2022\u3009."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105428_bib84","first-page":"18212","article-title":"Unveiling the Role of Programmed Cell Death Ligand-1 (PDL-1)expression in cervical squamous cell carcinoma: clinical insights and pathological implications","volume":"97","author":"Sulistiawati","year":"2026","journal-title":"Acta Biomed. Atenei Parm."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105428_bib85","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3390\/vaccines10071054","article-title":"Factors influencing men\u2019s attitudes toward hpv vaccination in males included in the chinese national immunization program","volume":"10","author":"Tao","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.critrevonc.2026.105428_bib86","unstructured":"Updated Cervical Cancer Screening Guidelines. (n.d.). Retrieved January 6, 2026, from \u3008https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2021\/04\/updated-cervical-cancer-screening-guidelines\u3009."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105428_bib87","first-page":"e155","article-title":"Human Papillomavirus infection and vaccination","volume":"31","author":"Valentino","year":"2016","journal-title":"J. Pediatr. Nurs. Nurs. Care Child. Fam."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105428_bib88","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ijc.29706","article-title":"CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies","volume":"138","author":"van Baars","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105428_bib89","unstructured":"What Is a Pap Test? (n.d.). Cleveland Clinic. Retrieved January 8, 2026, from \u3008https:\/\/my.clevelandclinic.org\/health\/diagnostics\/4267-pap-smear\u3009."},{"key":"10.1016\/j.critrevonc.2026.105428_bib90","unstructured":"What\u2019s the difference between Medicare and Medicaid? (12C.E., February 9). [FAQ]. \u3008https:\/\/www.hhs.gov\/answers\/medicare-and-medicaid\/what-is-the-difference-between-medicare-medicaid\/index.html\u3009."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105428_bib91","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ygyno.2020.08.006","article-title":"The effect of guideline-concordant care in mitigating insurance status disparities in cervical cancer","volume":"159","author":"Wu","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105428_bib92","first-page":"322","article-title":"Global burden of cervical cancer: current estimates, temporal trend and future projections based on the GLOBOCAN 2022","volume":"5","author":"Wu","year":"2025","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.critrevonc.2026.105428_bib93","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4103\/jcrt.JCRT_56_17","article-title":"The clinical application of HPV E6\/E7 mRNA testing in triaging women with atypical squamous cells of undetermined significance or low-grade squamous intra-epithelial lesion Pap smear: a meta-analysis","volume":"13","author":"Yang","year":"2017","journal-title":"J. Cancer Res. Ther."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105428_bib94","first-page":"319","article-title":"The Role of HPV E6 and E7 Oncoproteins in HPV-associated cervical carcinogenesis","volume":"37","author":"Yim","year":"2005","journal-title":"Cancer Res. Treatment Off. J. Korean Cancer Assoc."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105428_bib95","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.7150\/jca.32743","article-title":"Application of p16\/Ki-67 dual-staining cytology in cervical cancers","volume":"10","author":"Yu","year":"2019","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105428_bib96","doi-asserted-by":"crossref","DOI":"10.1515\/med-2024-1051","article-title":"Significance of negative cervical cytology and positive HPV in the diagnosis of cervical lesions by colposcopy","volume":"19","author":"Zhang","year":"2024","journal-title":"Open. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105428_bib97","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41392-024-02083-w","article-title":"Roles of human papillomavirus in cancers: Oncogenic mechanisms and clinical use","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.critrevonc.2026.105428_bib98","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12885-019-5492-9","article-title":"Performance of p16\/Ki67 immunostaining, HPV E6\/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS","volume":"19","author":"Zhu","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105428_bib99","doi-asserted-by":"crossref","DOI":"10.25259\/Cytojournal_112_2025","article-title":"The role of p16\/Ki-67 dual staining in cervical cancer screening and cervical precancerous lesions follow-up","volume":"22","author":"Zouzoulas","year":"2025","journal-title":"CytoJournal"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105428_bib100","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1038\/s41379-018-0101-z","article-title":"HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesions","volume":"31","author":"Zummeren","year":"2018","journal-title":"Mod. Pathol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282600315X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282600315X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:54:20Z","timestamp":1787108060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104084282600315X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":100,"alternative-id":["S104084282600315X"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105428","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging the gap between infection and detection: Biological, clinical, and health system contributors to diagnostic delay in HPV-associated cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105428"}}